Weight Gain Associated with Atypical Antipsychotic Use in Children and Adolescents: Prevalence, Clinical Relevance, and Management

Author： Stigler K.A.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.6, Iss.1, 2004-01, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amisulpride is an “atypical” antipsychotic associated with low weight gain

By Leucht Stefan   Wagenpfeil Stefan   Hamann Johannes   Kissling Werner  

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 112-115

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain

By Baptista Trino  

CNS Drugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 477-495

Adis International

Access to resources Recommend Favorite

Weight Gain with Antipsychotic Medications in Children and Adolescents

By  

Child and Adolescent Psychopharmacology News, Vol. 6, Iss. 6, 2001-12 ,pp. : 5-9

Guilford Publications Inc

Access to resources Recommend Favorite

Management of Atypical Antipsychotic Induced Prolactin Elevation in Children and Adolescents

By  

Child and Adolescent Psychopharmacology News, Vol. 18, Iss. 1, 2013-02 ,pp. : 1-6

Guilford Publications Inc

Access to resources Recommend Favorite

Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation: Review of the Literature and Clinical Suggestions

By Hasnain Mehrul  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite